Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03197363 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Białystok PLUS - Polish Longitudinal University Study

Study acronym: Bialystok+
StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 15, 2023 (before its estimated December 2024 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jul 2023 to Dec 2024
    • Study completion date: Jul 2023 to Dec 2029
    v8
  2. Study description expanded, about 22 wordsv7
  3. Re-verified, no change to tracked fieldsv6
  4. Start date changed from estimate of Sep 24, 2018 to Nov 5, 2018v5
  5. Start date: Jul 11, 2017 to Sep 24, 2018v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date changed from estimate of Jul 2017 to Jul 11, 2017v3
  2. Interventions: Discover of novel risk factors. (Other) to Discovering novel risk factors. (Other)
    • Study description expanded, about 9 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The main goal of the study is to provide a unique multidimensional picture of the health of the population with simultaneous optimal standards of sampling, processing and storing of data and biomaterial that will allow discovering novel mechanisms in the development and progression of common civilization diseases. In the effect it will improve prevention, diagnosis and treatment.
Trial Details
NCT Number NCT03197363
Lead Sponsor Medical University of Bialystok
Collaborators: University Medicine Greifswald, City of Białystok, Marshall's Office of Podlaskie Voivodship
Conditions
(from sponsor)		 Cardiovascular Diseases, Diabetes, Neuro-Degenerative Disease, Obesity, Pulmonary Disease, Neoplastic Disease
Related terms Cardiovascular Diseases, Diabetes Mellitus, Lung Diseases, Neoplasms, Obesity
Enrollment 10,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov